Health Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Health Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Following the introduction of life-saving glucocorticoid replacement 60 years ago, congenital adrenal hyperplasia (CAH) has evolved from being perceived as a paediatric disorder to being recognized as a lifelong, chronic condition affecting patients of all age groups. Increasing evidence suggests that patients with CAH have an increased risk to dev...
Alternative Titles
Full title
Health Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1159_000327794
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000327794
Other Identifiers
ISSN
1663-2818
E-ISSN
1663-2826
DOI
10.1159/000327794
